1. Home
  2. LPA vs NTHI Comparison

LPA vs NTHI Comparison

Compare LPA & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Logistic Properties of the Americas

LPA

Logistic Properties of the Americas

N/A

Current Price

$2.88

Market Cap

98.3M

Sector

N/A

ML Signal

N/A

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$3.09

Market Cap

106.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPA
NTHI
Founded
2013
2008
Country
Costa Rica
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.3M
106.0M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
LPA
NTHI
Price
$2.88
$3.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
24.4K
★ 177.7K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $39,990.00
Revenue This Year
$6.83
N/A
Revenue Next Year
$18.35
N/A
P/E Ratio
$11.25
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.04
$2.96
52 Week High
$4.73
$12.99

Technical Indicators

Market Signals
Indicator
LPA
NTHI
Relative Strength Index (RSI) 53.82 43.54
Support Level $2.85 $3.03
Resistance Level $3.27 $3.70
Average True Range (ATR) 0.14 0.34
MACD -0.01 0.00
Stochastic Oscillator 45.34 36.84

Price Performance

Historical Comparison
LPA
NTHI

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has four operating segments, based on geographic regions, consisting of Colombia, Peru, Mexico and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: